Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Transplant Toxicities

Autoimmune cytopenias after umbilical cord blood transplantation in adults with hematological malignancies: a single-center experience

Abstract

We describe incidence, clinical features, serological data, response to therapy and outcome of autoimmune cytopenias (ACs), including autoimmune hemolytic anemia (AIHA) and autoimmune thrombocytopenia (AIT) in a series of 281 consecutive adults with hematological malignancies that received single-unit umbilical cord blood transplantation (UCBT) at a single institution. AIHA was diagnosed in 15 patients at a median time of 181 days (range, 25–543), 12 of them had cold antibodies (IgM). The 3-year cumulative incidence (CI) of AIHA was 5.4% (CI 95% 2.7–8.1). Concomitant infections at the time of AIHA were present in 10 patients. Five out of nine patients that received corticosteroids achieved either a PR or a CR, whereas six out of eight patients that received rituximab responded. Four patients developed AIT giving a 3-year CI of 1.4% (CI 95% 0–2.8), concomitant infections were present in three of them. Multivariable analysis showed that development of chronic GVHD (relative risk (RR) 4; 95% CI 1.1–13.7; P=0.03) and diagnosis of CML (RR 4.3; 95% CI 1.5–12.7; P=0.008) were associated with an increased risk of AC. In conclusion, AIHA and AIT are relevant and clinically significant complications in UCBT recipients, especially among those that develop chronic GVHD. Response to therapy is sub-optimal, and rituximab should be considered as a therapeutic option, in this setting were most patients had cold AIHA and a serological profile similar to that seen in cold agglutinin disease.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Holbro A, Abinun M, Daikeler T . Management of autoimmune diseases after haematopoietic stem cell transplantation. Br J Haematol 2012; 157: 281–290.

    Article  CAS  Google Scholar 

  2. Sanz J, Arriaga F, Montesinos P, Ortí G, Lorenzo I, Cantero S et al. Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients. Bone Marrow Transplant 2007; 39: 555–561.

    Article  CAS  Google Scholar 

  3. Daikeler T, Labopin M, Ruggeri A, Crotta A, Abinun M, Hussein AA et al. New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation. Blood 2013; 121: 1059–1064.

    Article  CAS  Google Scholar 

  4. Sanz J, Boluda JCH, Martín C, González M, Ferrá C, Serrano D et al. Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen. Bone Marrow Transplant 2012; 47: 1287–1293.

    Article  CAS  Google Scholar 

  5. Sanz J, Sanz MA, Saavedra S, Lorenzo I, Montesinos P, Senent L et al. Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia. Biol Blood Marrow Transplant 2010; 16: 86–94.

    Article  Google Scholar 

  6. Montesinos P, Sanz J, Cantero S, Lorenzo I, Martín G, Saavedra S et al. Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation. Biol Blood Marrow Transplant 2009; 15: 730–740.

    Article  CAS  Google Scholar 

  7. Roback JD, Grossman BJ, Harris T, Hillyer CD (eds). Technical Manual 17th edn.American Association of Blood Banks: Arlington, 2011.

  8. Branch DR, SySiok Hian AL, Petz LD . A new elution procedure using a nonflammable organic solvent (abstract). Transfusion 1980; 20: 635.

    Google Scholar 

  9. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009; 113: 2386–2393.

    Article  CAS  Google Scholar 

  10. Gooley T, Leisenring W, Crowley J, Storer B . Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 1999; 18: 665–706.

    Article  Google Scholar 

  11. Fine J, Gray R . A proportional hazards model for subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496–509.

    Article  Google Scholar 

  12. Team RC. R: A Language and Environment for Statistical Computing, 2012.

  13. Chen FE, Owen I, Savage D, Roberts I, Apperley J, Goldman JM et al. Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant. Bone Marrow Transplant 1997; 19: 491–495.

    Article  CAS  Google Scholar 

  14. O'Brien TA, Eastlund T, Peters C, Neglia JP, Defor T, Ramsay NK et al. Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases. Br J Haematol 2004; 127: 67–75.

    Article  Google Scholar 

  15. Page KM, Mendizabal AM, Prasad VK, Martin PL, Parikh S, Wood S et al. Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation. Biol Blood Marrow Transplant 2008; 14: 1108–1117.

    Article  Google Scholar 

  16. Dovat S, Roberts RL, Wakim M, Stiehm ER, Feig SA . Immune thrombocytopenia after umbilical cord progenitor cell transplant: response to vincristine. Bone Marrow Transplant 1999; 24: 321–323.

    Article  CAS  Google Scholar 

  17. Chao MM, Levine JE, Ferrara JL, Cooling L, Cooke KR, Hutchinson RJ et al. Successful treatment of refractory immune hemolysis following unrelated cord blood transplant with Campath-1H. Pediatr Blood Cancer 2008; 50: 917–919.

    Article  Google Scholar 

  18. Jacobson CA, Turki AT, McDonough SM, Stevenson KE, Kim HT, Kaod G et al. Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2012; 18: 565–574.

    Article  CAS  Google Scholar 

  19. Cwynarski K, Goulding R, Pocock C, Dazzi F, Craddock C, Kaeda J et al. Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions. Bone Marrow Transplant 2001; 28: 581–586.

    Article  CAS  Google Scholar 

  20. Godder K, Pati AR, Abhyankar SH, Lamb LS, Armstrong W, Henslee-Downey PJ . De novo chronic graft-versus-host disease presenting as hemolytic anemia following partially mismatched related donor bone marrow transplant. Bone Marrow Transplant 1997; 19: 813–817.

    Article  CAS  Google Scholar 

  21. Rovira J, Cid J, Gutiérrez-García G, Pereira A, Fernández-Avilés F, Rosiñol L et al. Fatal immune hemolytic anemia following allogeneic stem cell transplantation: report of 2 cases and review of literature. Transfus Med Rev 2013; 27: 166–170.

    Article  Google Scholar 

  22. Petz LD . Cold antibody autoimmune hemolytic anemias. Blood Rev 2008; 22: 1–15.

    Article  Google Scholar 

  23. Berentsen S, Ulvestad E, Gjertsen BT, Hjorth-Hansen H, Langholm R, Knutsen H et al. Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients. Blood 2004; 103: 2925–2928.

    Article  CAS  Google Scholar 

  24. Matzinger P . The danger model: a renewed sense of self. Science 2002; 296: 301–305.

    Article  CAS  Google Scholar 

  25. Abrahamsen IW, Sømme S, Heldal D, Egeland T, Kvale D, Tjønnfjord GE . Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease. Haematologica 2005; 90: 86–93.

    PubMed  Google Scholar 

  26. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported in part by the Cooperative Research Thematic Network (RTICC). Grant RD12/0036/014 (ISCIII & ERDF). We thank David Pellicer and Shirley Weiss for data collection and management.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J Sanz.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sanz, J., Arango, M., Carpio, N. et al. Autoimmune cytopenias after umbilical cord blood transplantation in adults with hematological malignancies: a single-center experience. Bone Marrow Transplant 49, 1084–1088 (2014). https://doi.org/10.1038/bmt.2014.107

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2014.107

This article is cited by

Search

Quick links